The OASIS study is prospective, interventional, multi-center study to evaluate the safety and efficacy of the BlueWind RENOVA iStim™ implantable tibial neuromodulation System for the treatment of patients diagnosed with overactive bladder.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
282
Tibial implantable neuromodulation device
University of California Irvine
Orange, California, United States
≥50% Decrease in Mean Urinary Urgency Incontinence (UUI) Episodes
Proportion of responders at 6 months post system activation as demonstrated by ≥50% improvement in average number of urgency related incontinence episodes, measured by 7-day Patient Voiding Diary.
Time frame: 6 months
Safety - Number of Participants With Adverse Events
The primary safety endpoint was to assess adverse events from implantation to 12-months post-activation (Treatment Emergent Adverse Events).
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Kaiser Permanente
San Diego, California, United States
Norwalk Urology
Norwalk, Connecticut, United States
Florida Urology Partners
Tampa, Florida, United States
Comprehensive Urologic Care
Lake Barrington, Illinois, United States
Regional Urology, LLC
Shreveport, Louisiana, United States
Chesapeake Urology - Hanover
Hanover, Maryland, United States
Chesapeake Urology - Owing Mills
Owings Mills, Maryland, United States
Minnesota Urology
Woodbury, Minnesota, United States
Adult Pediatric Urology & Urogynecology
Omaha, Nebraska, United States
...and 13 more locations